AstraZeneca’s Tagrisso Shows Survival Benefit in Stage 3 EGFR Mutated Lung Cancer Patients
[메디칼업저버 양영구 기자] AstraZeneca’s lung cancer treatment Tagrisso (ingredient name: osimertinib) proved a survival benefit for the first time as an EGFR inhibitor in patients with stage 3 EGFR-mutated non-small cell lung cancer. AstraZeneca recently announced the top-line results of the phase 3 LAURA study. This study was conducted on patients with stage 3 non-mutable […]
Tenix’s New Refinement Method to Prevent Catastrophic Forgetting in Deep Learning Models
Preventing Catastrophic Forgetting with New Refinement Methods The Problem of Catastrophic Forgetting in Large Language Models When a large language model (LLM) has been refined with specific data for a particular purpose, the phenomenon of forgetting the original memorized information is known as ‘catastrophic forgetting’. This is a well-documented and challenging issue in the realm […]
